Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T19:03:05.168Z.
Calculation as of: 2026-10-06T19:03:05.168Z.
Quote observation: 2026-10-06T18:57:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 93909054c420831b7a71ade485d1565ba09f3c5b60377b98c71c30749e6fc511
PEG RATIO
N/A
PRF Technologies Ltd.
Market Cap
$72479.00
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| PRF Technologies Ltd. (PRFX) | $72479.00 | N/A |
| Akanda Corp. (AKAN)vs › | $63276.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $96088.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109777.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $31431.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29648.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6001.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $245237.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $354569.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
